April 23, 2014 4:32 AM ET

Pharmaceuticals

Company Overview of Merck Canada Inc.

Company Overview

Merck Canada Inc. is engaged in the research, development, manufacture, and sale of prescription medicines, vaccines, consumer, and animal health products. It offers prescription products for various therapeutic areas, such as cardiology, dermatology, endocrinology, immunology, neurology, oncology, urology, and others. The company provides consumer products, such as CLARITIN, AERIUS, and CHLOR-TRIPOLON for allergies; COPPERTONE for sun care; DR. SCHOLL'S for foot care; HYDRASENSE DRIXORAL, and CORICIDINII for nasal and cough/cold care; and RESTORALAX for digestive care. It offers veterinary medicines that include vaccines, anti-infective and antiparasitic drugs, a range of fertility manageme...

16711 Trans Canada Highway

Kirkland, QC H9H 3L1

Canada

Founded in 1982

Phone:

514-428-8600

Fax:

514-428-8675

Key Executives for Merck Canada Inc.

President and Managing Director
President of Merck Research Laboratories
Age: 54
President of Merck Global Human Health Europe & Canada
Vice President of Human Resources
Compensation as of Fiscal Year 2013.

Merck Canada Inc. Key Developments

B.C. Judge Oks Class-Action Lawsuit over Erectile Dysfunction Link to Drug for Baldness, Prostate Issues Against Merck Frosst Canada

A B.C. judge has ruled that men who suffered ongoing erectile dysfunction after taking prescription drugs to treat prostate problems and male pattern baldness will be able to pursue a class-action lawsuit against the drug maker. The lawsuit was brought by Michael Miller against Merck Frosst Canada, makers of Propecia and Proscar, two drugs that contain the medication finasteride. Miller was 25 in 2008, when he obtained a prescription for Proscar from his doctor. Although that drug is for the treatment of prostate problems, it contains the same medication as Propecia, used to treat male pattern baldness. Miller was advised to cut the five milligram tablet into four, making it roughly the same as the more expensive one-milligram Propecia tablets. Punnett ruled that the class-action lawsuit is appropriate, but certification is pending. The judge asked Miller's lawyers to provide an affidavit with information on potential litigants and asked both parties to provide information on expert reports they plan to submit. Merck has argued in this case and others that the plaintiffs have not provided scientific or medical evidence proving a link between the medication and the condition.

Merck Frosst Canada Ltd. - Special Call

Merck Frosst Canada Ltd. - Special Call

Federal Court Held Merck Frosst Canada Ltd. Liable to Apotex Inc. for Damages

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. is liable to Apotex Inc. for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

Similar Private Companies By Industry

Company Name Region
Germiphene Corporation Americas
Revive BioScience Inc. Americas
Sandoz Canada Inc. Americas
Afexa Life Sciences Inc. Americas
CEN Biotech, Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Merck Canada Inc., please visit www.merckfrosst.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.